Sponsor: North American Consortium for Histiocytosis - NACHO
Sponsor Study ID: 13-428
Study Title: International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis
CTO #: 102840
NCT Number: NCT02205762
Phase: II/III
Protocol Type: Treatment
Age Group: Children
Disease Sites: Other Hematopoietic
Study Objectives: The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).